A carregar...
Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
Avatrombopag is an orally-administered small molecule thrombopoietin receptor agonist. It was the third thrombopoietin receptor agonist approved for the treatment of immune thrombocytopenia and the first approved to treat periprocedural thrombocytopenia in patients with chronic liver disease (thereb...
Na minha lista:
| Publicado no: | J Blood Med |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6733339/ https://ncbi.nlm.nih.gov/pubmed/31565009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JBM.S191790 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|